Trial · NCT01566721
Results by group170
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 170
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With At Least 1 Adverse Event (AE) During the Treatment Period | Cohort A: SC Herceptin by Needle/Syringe | 88.6 | percentage of participants | ||
| Percentage of Participants With At Least 1 Adverse Event (AE) During the Treatment Period | Cohort B: SC Herceptin by SID | 89.0 | percentage of participants | ||
| Percentage of Participants With a Grade 3 or Higher AE During the Treatment Period | Cohort A: SC Herceptin by Needle/Syringe | 24.0 | 95% Confidence Interval 22.1 to 26.0 | percentage of participants | |
| Percentage of Participants With a Grade 3 or Higher AE During the Treatment Period | Cohort B: SC Herceptin by SID | 21.0 | 95% Confidence Interval 18.1 to 24.2 | percentage of participants | |
| Percentage of Participants With Treatment Interruption Due to an AE | Cohort A: SC Herceptin by Needle/Syringe | 9.8 | percentage of participants | ||
| Percentage of Participants With Treatment Interruption Due to an AE | Cohort B: SC Herceptin by SID | 10.4 | percentage of participants | ||
| Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID (Self-Administered) | 16.0 | Full Range 1 to 17 | cycles | |
| Number of Herceptin Cycles Received | Cohort A: SC Herceptin by Needle/Syringe | 18.0 | Full Range 1 to 19 | cycles | |
| Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID | 18.0 | Full Range 1 to 18 | cycles | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID (Self- Administered) | 1 Cycle Received | 2.7 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort A: SC Herceptin by Needle/Syringe | 1 Cycle Received | 1.0 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID | 1 Cycle Received | 0.8 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID (Self- Administered) | 2 Cycles Received | 1.3 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort A: SC Herceptin by Needle/Syringe | 2 Cycles Received | 0.5 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID | 2 Cycles Received | 0.4 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID (Self- Administered) | 3 Cycles Received | 1.1 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort A: SC Herceptin by Needle/Syringe | 3 Cycles Received | 0.5 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID | 3 Cycles Received | 0.1 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort B: SC Herceptin by SID (Self- Administered) | 4 Cycles Received | 1.6 | percentage of participants | |
| Percentage of Participants by Total Number of Herceptin Cycles Received | Cohort A: SC Herceptin by Needle/Syringe | 4 Cycles Received | 1.2 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01566721/results